This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Pneumococcal Infections, Streptococcus Pneumoniae Infections or Pneumococcal Pneumonia
and you are
between 18 and 50
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

This study is designed to evaluate the safety, tolerability, and immunogenicity of two investigational pneumococcal vaccines at three dose levels in healthy adults. Primary Objective: - To evaluate the safety and tolerability of two investigational pneumococcal vaccines. Observational Objective: - To evaluate the immunogenicity of the investigational pneumococcal vaccines.

Provided treatments

  • Biological: Pneumococcal Vaccine Formulation 1
  • Biological: Pneumococcal Vaccine Formulation 2
  • Biological: Pneumococcal Vaccine Formulation 3
  • Biological: Pneumococcal Vaccine Formulation 4
  • Biological: Pneumococcal Vaccine Formulation 5
  • Biological: Placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01444339. The sponsor of the trial is Sanofi and it is looking for 131 volunteers for the current phase.
Official trial title: